TOMORROW'S CELL THERAPIES, TODAY
Dead / Abandoned — Abandoned — no statement of use filed (as of 20 Nov 2023)
What this means for you
This application is over — abandoned 20 Nov 2023. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 88887199
- Mark type
- Stylized text
- Filed
- 24 Apr 2020
- Published for opposition
- 25 Aug 2020
- Abandoned
- 20 Nov 2023
- Attorney of record
- Rhett V. Barney
Goods and services
- Class 005 — Pharmaceuticals: Stem cells for medical purposes; Culture media for cultivating stem cells of animal or human origin; Pharmaceutical agents which reactivate the inherent functions of cells after freezing and thawing for diagnostic or therapeutic use; Stem cells for medical or veterinary use
Owner
- Pluristyx, Inc., Seattle, WA, US
- Pluristyx, Inc., Seattle, WA, US
Prosecution history
- 24 Sept 2025 — ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
- 02 Sept 2025 — ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
- 20 Nov 2023 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 20 Nov 2023 — ABANDONMENT - NO USE STATEMENT FILED
- 26 Apr 2023 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 25 Apr 2023 — SOU EXTENSION 5 GRANTED
- 20 Apr 2023 — SOU EXTENSION 5 FILED
- 20 Apr 2023 — SOU TEAS EXTENSION RECEIVED
- 22 Oct 2022 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 20 Oct 2022 — SOU EXTENSION 4 GRANTED
- 20 Oct 2022 — SOU EXTENSION 4 FILED
- 20 Oct 2022 — SOU TEAS EXTENSION RECEIVED
- 06 Apr 2022 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 04 Apr 2022 — SOU EXTENSION 3 GRANTED
- 04 Apr 2022 — SOU EXTENSION 3 FILED